Rx-360 Issues Guide On Remote Supplier Audits; CEO Warns They May Take Longer At First
Remote Audits Should Consider Confidentiality Issues
Manufacturers should expect that remote audits of suppliers may take longer than onsite ones until they get more familiar with these audits; it is also important to abide by data confidentiality rules and take frequent breaks when conducting these audits, says Rx-360 CEO.
You may also be interested in...
Expert outlines how pharma can create resilient and secure supply chains and some benefits of localization.
Agency responds to COVID-19 pandemic's US arrival by suspending domestic surveillance inspections and non-critical for-cause and preapproval inspections.
Drug manufacturers formed the Rx-360 consortium as a vanguard in protecting the global supply chain of ingredients for Rx and nonprescription drug products from threats like the heparin adulteration potentially linked to 146 U.S. deaths in 2008